AssuredPartners Investment Advisors LLC Takes $649,000 Position in The Clorox Company (NYSE:CLX)

AssuredPartners Investment Advisors LLC acquired a new stake in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 3,996 shares of the company's stock, valued at approximately $649,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Clorox by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company's stock valued at $2,518,517,000 after purchasing an additional 124,428 shares in the last quarter. State Street Corp grew its holdings in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after acquiring an additional 245,525 shares during the period. Geode Capital Management LLC raised its position in Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after acquiring an additional 33,970 shares in the last quarter. Stifel Financial Corp lifted its holdings in Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock valued at $380,370,000 after acquiring an additional 37,967 shares during the last quarter. Finally, Amundi raised its holdings in shares of Clorox by 42.6% in the 4th quarter. Amundi now owns 1,032,283 shares of the company's stock worth $165,816,000 after purchasing an additional 308,234 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

NYSE:CLX traded up $1.23 during mid-day trading on Monday, hitting $147.51. The company's stock had a trading volume of 370,125 shares, compared to its average volume of 1,275,582. The company has a market capitalization of $18.17 billion, a price-to-earnings ratio of 40.33, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The stock has a fifty day moving average of $151.34 and a 200-day moving average of $159.00.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the firm posted $2.16 earnings per share. As a group, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.31%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is currently 133.33%.

Analysts Set New Price Targets

Several research firms have weighed in on CLX. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Barclays cut their price objective on Clorox from $140.00 to $139.00 and set an "underweight" rating on the stock in a research note on Thursday. Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Evercore ISI boosted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $159.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.